ArticleClinical and experimental immunology2004

Methotrexate reduces antibody responses to recombinant human alpha-galactosidase A therapy in a mouse model of Fabry disease.

R D Garman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.